We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fusobacterium nucleatum load in MSI colorectal cancer subtypes.
- Authors
Ono, Tomoyuki; Yamaguchi, Tatsuro; Takao, Misato; Kojika, Ekumi; Iijima, Takeru; Horiguchi, Shin-ichiro
- Abstract
Background: Fusobacterium nucleatum (F. nucleatum) infection may lead to colorectal cancer (CRC) development in the context of microsatellite instability (MSI). To date, however, the relationship between F. nucleatum load and MSI CRC subtypes has not been clarified. Methods: One hundred seventy-nine consecutive patients with CRC were enrolled in the present study. In 94 patients with MSI CRC, 32 had hereditary MSI CRC from Lynch syndrome, 62 had sporadic MSI CRC, while the remaining 85 had microsatellite stable (MSS) CRC. The association of the F. nucleatum load with each CRC subtype and the patients' clinicopathological characteristics was examined. Results: Of the 179 patients with CRC, 158 (88.3%) were F. nucleatum-positive. A high F. nucleatum load was found in 84.4% (27/32), 96.8% (60/62), and 83.5% (71/85) of the patients with hereditary MSI CRC, sporadic MSI CRC, and MSS CRC, respectively (P = 0.024). In terms of clinicopathological features, a high F. nucleatum load was significantly associated with female, right-sided CRC, BRAF V600E, CpG island methylator phenotype-positive CRC, and MSI CRC (P = 0.008, P = 0.015, P = 0.007, P = 0.006, and P < 0.001, respectively). However, the clinicopathological characteristics did not differ significantly by F. nucleatum load between hereditary and sporadic MSI CRCs without tumor depth. Conclusions: The F. nucleatum load was higher in hereditary MSI CRC than in MSS CRC as well as sporadic MSI CRC. These findings may contribute to preventing CRC in hereditary MSI CRC through appropriate intervention.
- Subjects
COLORECTAL cancer; HEREDITARY nonpolyposis colorectal cancer; FUSOBACTERIUM; MICROSATELLITE repeats; BRAF genes
- Publication
International Journal of Clinical Oncology, 2022, Vol 27, Issue 10, p1580
- ISSN
1341-9625
- Publication type
Article
- DOI
10.1007/s10147-022-02218-5